The U.S. Food and Drug Administration (FDA) will announce a new warning on Johnson & Johnson’s (J&J) COVID vaccine saying the shot has been linked to Guillain–Barré syndrome (GBS), a “serious but rare” autoimmune disorder. The Washington Post attributed the news to “four individuals familiar with the situation.”
Ninds.nih via (CHD) Guillain-Barré syndrome (GBS) is a rare and potentially deadly neurological disorder in which the body’s immune system mistakenly attacks part of its peripheral nervous system—the network of nerves located outside of the brain and spinal cord. There is no known cure for Guillain-Barré syndrome. However, some therapies can lessen the severity of the illness and shorten recovery time.
According to The New York Times, the chances of developing GBS after receiving the J&J shot is three to five times higher than would be expected in the general population in the U.S. About 100 preliminary reports in the U.S. of GBS have been detected after receiving J&J’s vaccine, the Centers for Disease Control and Prevention (CDC) said in a statement to CNN today. Most cases were reported about two weeks after vaccination, mostly in men 50 and older.
While the cause of GBS is not fully known, it often follows infection with a virus and has been linked to other vaccines. The FDA has concluded the benefits of the vaccine outweigh any danger, but will include the proviso in fact sheets about the drug for providers and patients.
GBS can range from a very mild case with brief weakness to nearly devastating paralysis, leaving the person unable to breathe independently. Fortunately, most people eventually recover from even the most severe cases of GBS. After recovery, some people will continue to have some degree of weakness.
Guillain-Barré syndrome can affect anyone. It can strike at any age (although it is more frequent in adults and older people) and both sexes are equally prone to the disorder. GBS is estimated to affect about one person in 100,000 each year.
About 100 preliminary reports in the U.S. of GBS have been detected after receiving J&J’s vaccine, the Centers for Disease Control and Prevention (CDC) said in a statement to CNN today. Most cases were reported about two weeks after vaccination, mostly in men 50 and older.
FROM BNI: “I didn’t get GBS after a vaccination, but following a mild virus. Little by little, I lost the use of my hands and legs, as GBS had attacked my spine. I was hospitalized for several weeks and given large doses of Cortizone for more than a year afterwards. Physical therapists had to teach me how to walk all over again. It took about a year before I could move semi-freely and I had chronic back pain from it for many years, thereafter.
Even today, decades later, I get a distinctive pain in my lower back after walking around for several hours on hard surfaces, and I recognize it as the GBS pain – different than any other.
Thankfully, I can still ride and jump horses which actually helps to strengthen my back.
But I was one of the lucky ones. My doctor had a 16 year old patient who died from GBS after he had to be confined to an iron lung for a year just so he could breathe.”
OMG! The girl in the video below could have been me when I was 15 and in the hospital with GBS:
In Dec. 2020, a study allegedly found no link between COVID-19 and Guillain-Barre Syndrome:
react.etvbharat After some reports linked Covid-19 with Guillain-Barre Syndrome (GBS) — a rare disorder where the body’s immune system attacks nerves and can lead to respiratory failure and death, a new study found no association between them.
The study, published in the journal Brain, have found no significant association between COVID-19 and the potentially paralyzing and sometimes fatal neurological condition Guillain-Barre syndrome.
Most COVID-19 vaccinations are based on the SARS-CoV-2 spike protein, which drives a complex immune response creating antibodies to fight infection,” the study authors wrote. “Our analysis shows SARS-CoV-2 contains no additional immunogenic material known or proven to drive GBS. Concerns that Covid vaccination might cause GBS in any significant numbers are therefore almost certainly unfounded,” they noted.
Just last March, doctors were saying there is no connection between COVID-19 vaccines and Guillain-Barré Syndrome:
What causes Guillain-Barré syndrome?
The exact cause of GBS is not known. Researchers don’t know why it strikes some people and not others. It is not contagious or inherited.
What they do know is that the affected person’s immune system begins to attack the body itself. It is thought that, at least in some cases, this immune attack is initiated to fight an infection and that some chemicals on infecting bacteria and viruses resemble those on nerve cells, which, in turn, also become targets of attack.
Since the body’s own immune system does the damage, GBS is called an autoimmune disease (“auto” meaning “self”). Normally the immune system uses antibodies (molecules produced in an immune response) and special white blood cells to protect us by attacking infecting microorganisms (bacteria and viruses). In Guillain-Barré syndrome, however, the immune system mistakenly attacks the healthy nerves.
Most cases usually start a few days or weeks following a respiratory or gastrointestinal viral infection. Occasionally surgery will trigger the syndrome. In rare cases vaccinations may increase the risk of GBS. Recently, some countries worldwide reported an increased incidence of GBS following infection with the Zika virus.
Guillain-Barré syndrome can be a devastating disorder because of its sudden and rapid, unexpected onset of weakness—and usually actual paralysis. Fortunately, 70% of people with GBS eventually experience full recovery. With careful intensive care and successful treatment of infection, autonomic dysfunction and other medical complications, even those individuals with respiratory failure usually survive.
Guillain-Barré Syndrome Fact Sheet
What is Guillain-Barré syndrome?
What causes Guillain-Barré syndrome?
What are the symptoms of GBS?
What happens in GBS?
How does nerve damage occur?
What disorders are related to GBS?
How is Guillain-Barré syndrome diagnosed?
How is Guillain-Barré treated?
What is the long-term outlook for those with Guillain-Barré syndrome?
What research is being done?
Where can I get more information?